UPDATE 1-Neurocrine gets U.S. approval for Parkinson’s therapy, COVID-19 delays launch

UPDATE 1-Neurocrine gets U.S. approval for Parkinson’s therapy, COVID-19 delays launch
Neurocrine Biosciences Inc's said on Monday its add-on treatment for patients with Parkinson's disease had received U.S. approval, but would delay launch until later this year due to disruptions ... read more
Source: Bing NewsPublished on 2020-04-27